SERP from Sarcandra glabra improves cognitive function in diabetic encephalopathy by regulating gut microbiota, lipid metabolism, and butyric acid levels. Promising treatment option targeting "microbiota-gut-brain axis".
Researchers studied the effects of Sarcandra glabra on ulcerative colitis. Its traditional use in treating digestive diseases suggests potential therapeutic benefits for UC. Important for developing new treatments.
Researchers studied the molecule CADPE and its potential to prevent colorectal cancer in a mouse model induced by the use of DMH and DSS. Results could contribute to future cancer prevention strategies.
Researchers discovered new compounds from the roots of a plant and determined their structures using various techniques. These compounds showed promising anti-inflammatory and anti-proliferation properties in the lab.
Researchers isolated Sarglamides A-E from a plant and found that compounds - and - have unique structures. They proposed possible pathways for their creation and found that compounds - can reduce inflammation.
Researchers isolated nine coumarins from the Sarcandra glabra plant, including a newly discovered pair of enantiomers. They tested all the compounds for acetylcholinesterase inhibiting activity and found that compound 3 showed the most significant effect with an IC value of 1.982±0.003 μM. The study confirms the potential therapeutic properties of coumarins and its ability to target Alzheimer's disease.
Isofraxidin is a molecule found in plants that are useful for brain diseases. It is extracted from plants like Sarcandra glabra, Apium graveolens, and Siberian Ginseng.